In early June, at the invitation of the European Commission to Brussels (Belgium), I toured some fascinating AI and blockchain-based projects, which the Commission is funding. Across industrial sectors, from healthcare to energy, from construction to retail, engineers are creating new technologies with potentially disruptive implications for the current architectural order of the global economy. One of the technologies, an “AI doctor”, shows great promise for the future of healthcare in Africa.
The solution is called CareAi: an AI-powered computing system anchored on blockchain that can diagnose infectious diseases, such as malaria, typhoid fever, and tuberculosis, within seconds. The platform is engineered to serve the invisible demographic of migrants, ethnic minorities, and those unregistered within traditional healthcare systems. By bringing AI and blockchain together, CareAi uses an anonymous distributed healthcare architecture to deliver health services to patients anonymously. This makes it possible for these invisible cohorts to get access to basic healthcare, and useful contextual information without compromising their identities, for fear of deportation. This is important, as without access to health services, these communities might pose health risks to the wider population.
CareAi has three components, which include the machine, a finger prick, and a lab-on-a-chip — a mature technology that was originally pioneered by George Whitesides, a chemistry Professor at Harvard University. To use it, a finger is pricked for a drop of blood, and the blood is deposited onto the chip, which is then inserted into the machine. The blood sample is anonymized and then analyzed by the CareAi AI-based health assistant that references a vast array of medical and diagnosing libraries, dispensing advice with a corresponding rating of confidence. CareAi’s diagnosis is based on a statistical analysis of all of that data: if I see “A” in your blood and medical journals say that means you have malaria, CareAi can say whether you have malaria up to a certain confidence level. Based on the blood sample, the device would diagnose a disease where one exists. The outcome is delivered on the machine screen with a printout, providing confidence of analysis and further actions which may include prescriptions at participating pharmacies, or escalation for medical attention with NGO doctors who supply anonymous medical treatments.
Image Credit: KATERYNA/KONSCIENCE PHOTO LIBRARY/Getty Images
News This Week
Immune Aspects of Biopharmaceuticals and Nanomedicines 1st Edition Raj Bawa, Janos Szebeni, Thomas J Webster, Gerald F. Audette The enormous advances in the immunology of biotherapeutics and nanomedicines in the past two decades have [...]
LAS CRUCES, N.M. — Members of an independent NASA safety panel said they were worried that the Oct. 11 Soyuz launch failure could make safety concerns with the agency's commercial crew program even worse. [...]
Canadian astronaut Col. Chris Hadfield (Ret.) on Friday said that human travel to space will happen sooner than we think, adding that the first destination will likely be a return trip to the moon. [...]
Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety. Concerns stem from inefficient [...]
Following the discovery of graphene in 2003, there has been considerable interest in other types of 2D materials. However, splitting a bulk crystal material into 2D flakes for use in electronics has proven hard [...]
The digital economy is set to unlock tremendous economic value for countries over time. But a common setback for the use of various new technologies is their vulnerability to hackers. That's because companies and [...]
Nanomedical Device and Systems Design: Challenges, Possibilities, Visions now available to rent on Kindle
To accommodate students who wish to read the book at an affordable cost, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions by Frank Boehm (CEO NanoApps Medical Inc.) is available to rent on Kindle. This book benefits [...]
The last five years has seen a surge of attacks on the healthcare industry, with the largest breaches impacting as many as 80 million people. In July this year, it was revealed that 150,000 [...]
The Nanoaugmented Materials Industry Summit (NAUM) 2018 in Shanghai on October 31 will gather the world’s leading companies who use and apply graphene nanotubes to share exciting results. This year the event is opening [...]
Any truck operator knows that hydraulics do the heavy lifting. Water does the work because it's nearly incompressible at normal scales. But things behave strangely in nanotechnology, the control of materials at the scale [...]
Myeloperoxidase - an enzyme naturally found in our lungs - can biodegrade pristine graphene, according to the latest discovery of Graphene Flagship partners in CNRS, University of Strasbourg (France), Karolinska Institute (Sweden) and University [...]
In today’s hospitals and healthcare clinics, a new doctor’s new assistant is now often on the job — in the form of artificial intelligence. Whether it’s analyzing medical images or guiding robots that assist [...]
Healthcare cybersecurity will be one of the top 10 challenges, issues, and/or opportunities facing healthcare executives next year, according to a new poll by the Healthcare Executive Group (HCEG). Healthcare cybersecurity covers such issues [...]
A research team has developed a nano-platform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma. Drug resistance to chemotherapy is a significant clinical and financial [...]